Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP476401.RARLkfmH7LxSZLvYjjLQUJILetn_vz4m7RVoW9JQL99Lw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP476401.RARLkfmH7LxSZLvYjjLQUJILetn_vz4m7RVoW9JQL99Lw130_assertion type Assertion NP476401.RARLkfmH7LxSZLvYjjLQUJILetn_vz4m7RVoW9JQL99Lw130_head.
- NP476401.RARLkfmH7LxSZLvYjjLQUJILetn_vz4m7RVoW9JQL99Lw130_assertion description "[In the present study, we examined the effects of 2 IKK inhibitors, N-(1,8-Dimethylimidazo[1,2-a]quinoxalin-4-yl)-1,2-ethanediamine hydrochloride (BMS-345541) and 2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide (TPCA-1), on IFN action in several human glioma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP476401.RARLkfmH7LxSZLvYjjLQUJILetn_vz4m7RVoW9JQL99Lw130_provenance.
- NP476401.RARLkfmH7LxSZLvYjjLQUJILetn_vz4m7RVoW9JQL99Lw130_assertion evidence source_evidence_literature NP476401.RARLkfmH7LxSZLvYjjLQUJILetn_vz4m7RVoW9JQL99Lw130_provenance.
- NP476401.RARLkfmH7LxSZLvYjjLQUJILetn_vz4m7RVoW9JQL99Lw130_assertion SIO_000772 22509977 NP476401.RARLkfmH7LxSZLvYjjLQUJILetn_vz4m7RVoW9JQL99Lw130_provenance.
- NP476401.RARLkfmH7LxSZLvYjjLQUJILetn_vz4m7RVoW9JQL99Lw130_assertion wasDerivedFrom befree-20150227 NP476401.RARLkfmH7LxSZLvYjjLQUJILetn_vz4m7RVoW9JQL99Lw130_provenance.
- NP476401.RARLkfmH7LxSZLvYjjLQUJILetn_vz4m7RVoW9JQL99Lw130_assertion wasGeneratedBy ECO_0000203 NP476401.RARLkfmH7LxSZLvYjjLQUJILetn_vz4m7RVoW9JQL99Lw130_provenance.